We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ABVC market cap is 8.15M. The company's latest EPS is USD -0.9691 and P/E is -0.76.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 589k | 128k | 6k | 16k | 2k |
| Operating Income | -8.28M | -1.91M | -3.45M | -902k | -1.96M |
| Net Income | -4.86M | -1.82M | -3.52M | -2.06M | -3.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 702k | 483k | 356k | 970k | 152k |
| Operating Income | -3.46M | -8.51M | -11.71M | -15.11M | -8.22M |
| Net Income | -3.64M | -9.79M | -12.84M | -16.42M | -10.52M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.86M | 10.74M | 9.32M | 16.59M | 14.49M |
| Total Liabilities | 6.62M | 9M | 9.69M | 7.53M | 6.36M |
| Total Equity | 3.24M | 1.74M | -367k | 9.06M | 8.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.93M | 11.61M | 13.7M | 9.86M | 14.49M |
| Total Liabilities | 7.05M | 8.95M | 4.83M | 6.62M | 6.36M |
| Total Equity | -125k | 2.66M | 8.87M | 3.24M | 8.13M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.4M | -1.5M | -2.4M | -3.76M | -4.24M |
| Investing | -1.72M | N/A | -441k | -514k | -360k |
| Financing | 4.01M | 2.21M | 2.18M | 3.83M | 3.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.14M | -4.56M | -7.6M | -7.4M | -4.24M |
| Investing | -35k | -225k | -806k | -1.72M | -360k |
| Financing | 3.09M | 9.57M | 10M | 4.01M | 3.92M |
| Market Cap | 8.15M |
| Price to Earnings Ratio | -0.76 |
| Price to Sales Ratio | 52.86 |
| Price to Cash Ratio | 134.55 |
| Price to Book Ratio | 0.99 |
| Dividend Yield | - |
| Shares Outstanding | 10.85M |
| Average Volume (1 week) | 143.74k |
| Average Volume (1 Month) | 138.94k |
| 52 Week Change | -86.60% |
| 52 Week High | 6.87 |
| 52 Week Low | 0.6739 |
| Spread (Intraday) | 0.04 (5.14%) |
| Company Name | ABVC BioPharma Inc |
| Address |
401 ryland st ste 200-a, reno reno, nevada 89502 |
| Website | https://www.abvcpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
